Nephrotic Syndrome and Adult Minimal Change Disease — Advanced Interactive Case

NEPHROHUB • ADVANCED INTERACTIVE CASE

Educational disclaimer: This postgraduate case is for education and does not replace bedside assessment, local protocols, senior nephrology input, current prescribing information, or patient-specific evaluation.

Difficulty and format

Difficulty: Advanced. Format: Four-stage branching outpatient nephrology case with a relapse and escalation branch.

Learning objectives

By the end of this case, learners should be able to confirm nephrotic syndrome; construct a focused primary-versus-secondary differential; recognize why adult minimal change disease requires biopsy confirmation; use individualized supportive care; monitor glucocorticoid therapy safely; distinguish an isolated relapse from frequent relapse or steroid dependence; and select an escalation strategy when glucocorticoid toxicity or recurrent disease becomes clinically important.

Stage 1 — Confirm nephrotic syndrome and plan the biopsy

Presentation

Ms. Jennifer Park is a 28-year-old Korean-American graduate student with three months of progressive lower-extremity edema, morning facial puffiness, foamy urine, fatigue, and a 12-pound weight gain. She has no significant medical history and takes an oral contraceptive. She denies recent infection, rash, arthralgia, dysuria, flank pain, new medications, or supplement exposure. Blood pressure is 118/76 mmHg, BMI 24.5 kg/m², jugular venous pressure is not elevated, lungs are clear, and there is bilateral pitting edema to the mid-thighs.

Serum albumin is 2.1 g/dL, total protein 4.8 g/dL, creatinine 0.9 mg/dL, and eGFR 95 mL/min/1.73 m². Urinalysis shows 4+ protein, trace blood, oval fat bodies, and fatty casts without red-cell casts. Protein excretion is approximately 8.2 g/day. Total cholesterol is 385 mg/dL, LDL 285 mg/dL, HDL 28 mg/dL, and triglycerides 420 mg/dL.

Decision point 1 — Initial approach

Preferred decision: Confirm nephrotic syndrome using heavy proteinuria, hypoalbuminemia, and edema, then evaluate kidney function, urine sediment, blood pressure, volume status, secondary causes, medication exposure, pregnancy considerations, and thromboembolic symptoms. In an adult with unexplained nephrotic syndrome, kidney biopsy is required to establish minimal change disease and guide treatment. Do not label this as minimal change disease from the presentation alone.

The differential includes minimal change disease, membranous nephropathy, focal segmental glomerulosclerosis, lupus nephritis, infection-associated disease, monoclonal gammopathy-related disease, medication-associated disease, and selected malignancy-associated conditions. The oral contraceptive is relevant to thrombotic-risk assessment but does not explain the glomerular lesion by itself.

Stage 2 — Evaluate secondary causes and interpret the biopsy

Secondary-cause evaluation

Complement levels are normal. Hepatitis B and C testing, HIV testing, ANA, anti-dsDNA, serum and urine electrophoresis, and immunofixation are unrevealing. Syphilis testing is non-reactive. Thyroid testing is normal. Age-appropriate preventive and malignancy assessment is reviewed without a concerning finding. Additional tests should be selected according to history, examination, ethnicity, exposures, family history, and biopsy findings rather than ordered as an indiscriminate panel.

Decision point 2 — Biopsy interpretation

Kidney biopsy shows normal glomeruli by light microscopy, negative immunofluorescence for IgG, IgA, IgM, C3, and C1q, and diffuse podocyte foot-process effacement without electron-dense deposits. Tubules, interstitium, and vessels are unremarkable.

Preferred decision: These findings establish minimal change disease. In adults, the biopsy is central to diagnosis because clinically similar nephrotic presentations may reflect membranous nephropathy, FSGS, or immune-complex disease. Before immunosuppression, confirm that the clinical and pathology findings are concordant and that secondary causes have been reasonably assessed.

Stage 3 — Initial therapy and supportive care

Decision point 3 — Glucocorticoid strategy

Preferred decision: Start high-dose oral glucocorticoid therapy, commonly prednisone approximately 1 mg/kg/day up to a local maximum, with planned reassessment of proteinuria, edema, kidney function, blood pressure, glucose, mood, sleep, infection risk, bone health, and reproductive considerations. Continue the initial regimen for a guideline-consistent period after remission and then taper; exact duration should follow current KDIGO/local protocol and response rather than an inflexible universal schedule.

Adults may respond more slowly than children. Absence of remission early in treatment does not automatically prove steroid resistance. Persistent nephrotic syndrome after an adequate course requires reassessment of adherence, secondary causes, biopsy adequacy, and the diagnosis.

Supportive care branch

Use dietary sodium restriction and titrated loop diuretic therapy for edema, monitoring weight, blood pressure, orthostatic symptoms, creatinine, potassium, magnesium, and volume status. Avoid excessive protein restriction; provide adequate nutrition and individualized dietary counseling. An ACE inhibitor or ARB may be considered for antiproteinuric benefit if blood pressure, kidney function, potassium, and volume status permit, but it is not mandatory in a normotensive patient and should be withheld or adjusted when hypotension, acute kidney injury, or active volume depletion develops.

Assess thromboembolic symptoms and bleeding risk. Severe hypoalbuminemia, proteinuria, underlying histology, immobility, prior thrombosis, oral-estrogen exposure, kidney function, and bleeding risk should inform any prophylactic-anticoagulation discussion. A high D-dimer alone does not mandate anticoagulation. Lipid management should be individualized according to persistence of dyslipidemia and overall cardiovascular risk.

Review vaccinations, infection prevention, bone protection, glucose and blood-pressure monitoring, and gastrointestinal risk. Acid-suppression therapy is not automatically required for every patient receiving prednisone; use it when gastrointestinal risk justifies it.

Stage 4 — Response, relapse, and escalation

Response assessment

The patient’s edema begins to improve during the third week. By week six, urine protein excretion is below 300 mg/day and serum albumin is 3.8 g/dL. This is complete remission. Remission definitions and urine monitoring should be explicit and consistent.

Decision point 4A — First relapse

At 18 months, proteinuria returns to 4.2 g/day with mild edema. Confirm relapse with repeat quantitative urine testing and assess for infection, medication changes, pregnancy, thrombosis, kidney-function change, and adherence. A single relapse is not the same as frequent-relapsing disease or steroid dependence.

Preferred decision: Treat an infrequent relapse with glucocorticoid therapy according to current guideline/local protocol, while minimizing avoidable steroid exposure and monitoring for complications. Discuss home urine-protein monitoring and a clear plan for early contact if edema or proteinuria recurs.

Decision point 4B — Frequent relapse or steroid toxicity

If the patient develops frequent relapses, steroid dependence, serious glucocorticoid toxicity, or inability to taper without recurrence, reassess the diagnosis and discuss steroid-sparing therapy. Options may include rituximab, a calcineurin inhibitor, cyclophosphamide, or a mycophenolic-acid analogue, selected according to relapse phenotype, fertility priorities, infection risk, comorbidities, prior treatment, and local expertise. Failure to respond after an adequate initial glucocorticoid course requires re-evaluation of biopsy adequacy, secondary causes, adherence, and alternative diagnoses before labeling the disease steroid resistant.

Expert synthesis

This case demonstrates why adult nephrotic syndrome requires a structured diagnostic pathway and biopsy confirmation before disease-specific therapy. Biopsy-proven minimal change disease usually has an excellent kidney prognosis, but adult responses can be slower and relapses are common. The safest plan combines guideline-consistent glucocorticoids with individualized edema management, avoidance of unnecessary protein restriction, careful assessment of thrombotic and bleeding risk, monitoring for treatment toxicity, and a clear escalation pathway for frequent relapses, steroid dependence, or steroid toxicity.

Advanced Self-Assessment

Complete the 10-question Advanced self-assessment below. Detailed explanations are provided after submission.

NephroHub assessment: Advanced level • 10 questions • clinical reasoning focused

Nephrotic Syndrome and Adult Minimal Change Disease — Advanced

1 / 10

Which follow-up plan is most appropriate after remission?

Stop monitoring once albumin normalizes

Continue indefinite high-dose prednisone to prevent any relapse

Provide a universal protein restriction and prophylactic proton-pump inhibitor prescription

Use urine-protein and clinical monitoring, review steroid toxicity and vaccination/bone health, provide an early-relapse plan, and individualize future steroid-sparing discussions

2 / 10

After an adequate initial glucocorticoid course, the patient remains nephrotic. What is the best next approach?

Reassess adherence, biopsy adequacy, secondary causes, medication effects, and alternative diagnoses before labeling steroid resistance; then involve a nephrologist in selecting escalation therapy

Continue the same dose indefinitely without reassessment

Assume that minimal change disease is impossible and discharge the patient

Give empiric anticoagulation as the primary disease treatment

3 / 10

At 18 months, proteinuria returns to 4.2 g/day with mild edema after a sustained complete remission. Which interpretation is most accurate?

This automatically proves steroid-dependent disease

This is a first relapse that should be confirmed quantitatively and managed according to the infrequent-relapse pathway unless further pattern emerges

This proves steroid resistance

This requires immediate cyclophosphamide without reassessment

4 / 10

The patient has albumin 2.1 g/dL, an elevated D-dimer, and uses an oral contraceptive. What is the most appropriate next step?

Start anticoagulation solely because the D-dimer is elevated

Ignore thrombosis because she is young and ambulatory

Assess thromboembolic risk, bleeding risk, histology, immobility, estrogen exposure, kidney function, and symptoms before specialist-directed prophylaxis decisions

Stop all diuretics to prevent thrombosis

5 / 10

Which supportive-care plan is safest for this normotensive patient with marked edema?

Prescribe a fixed high-dose loop diuretic without checking creatinine or electrolytes

Use sodium restriction and titrated loop diuresis with monitoring of weight, volume status, kidney function, and electrolytes; consider antiproteinuric therapy only if tolerated

Restrict protein severely to less than 0.4 g/kg/day

Start an ACE inhibitor regardless of blood pressure or volume status

6 / 10

Which initial treatment statement is most appropriate for biopsy-proven adult minimal change disease with nephrotic syndrome?

Use high-dose oral glucocorticoid therapy with a planned reassessment and guideline-consistent taper after remission

Give a three-day antibiotic course and reassess proteinuria

Start a calcineurin inhibitor in every patient before glucocorticoids

Use low-dose prednisone indefinitely without monitoring

7 / 10

The biopsy shows normal glomeruli by light microscopy, negative immunofluorescence, and diffuse foot-process effacement without electron-dense deposits. Which diagnosis is most likely?

Membranous nephropathy

Lupus nephritis

Focal segmental glomerulosclerosis

Minimal change disease

8 / 10

Which approach best describes evaluation for secondary causes in this young adult?

Order a focused, history- and pathology-informed evaluation including autoimmune, infection, monoclonal, medication, and selected malignancy assessment

Order only ANA because all secondary causes are autoimmune

Order only hepatitis serology because infections are the usual cause

Omit secondary-cause evaluation after a normal complement level

9 / 10

In an adult with unexplained nephrotic syndrome and preserved kidney function, what is the most appropriate next diagnostic principle?

Start empiric long-term immunosuppression without tissue diagnosis

Diagnose minimal change disease from oval fat bodies

Perform kidney biopsy after a focused secondary-cause evaluation because biopsy establishes the lesion and guides therapy

Avoid biopsy if serum albumin is below 2.5 g/dL

10 / 10

A 28-year-old woman has edema, serum albumin 2.1 g/dL, and urine protein excretion of 8.2 g/day. Which finding most directly completes the clinical diagnosis of nephrotic syndrome?

Isolated microscopic hematuria without protein quantification

Heavy proteinuria with hypoalbuminemia and edema

Normal serum creatinine alone

Your score is

The average score is 90%

By Wordpress Quiz plugin

References

KDIGO Glomerular Diseases Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney International guideline.
KDIGO Glomerular Diseases guideline resources and updates.
Palmer SC, Nand K, Strippoli GFM. Interventions for minimal change disease in adults with nephrotic syndrome. Cochrane review.

NephroHub • Clinical education for postgraduate nephrology